Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu(Medigene (Germany)), Wensheng Wei(Peking University), Yanan Zhou(Liaoning Normal University), Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Youchun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Huang(Huizhou University), Ayijiang Yisimayi(Peking University), Xiaoliang Sunney Xie(Peking University), Zhuo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Huixian Tang(Peking University), Xia Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Feng Tian(Sun Yat-sen University), Li Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Weijin Huang(National Institutes for Food and Drug Control), Shuaiyao Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zongyi Yi(Beijing Biocytogen (China)), Wenhai Yu(Kunming Institute of Zoology), Feng Chen(Northwestern University), Chunhui Wang(General Hospital of Shenyang Military Region), Jianwei Wang(Zhejiang Cancer Hospital), Shuo Liu(Wuhan University), Xiaoxue Zhang(Case Western Reserve University), Yun Yang(Kunming Institute of Zoology), Chengyun Yang(Kunming Institute of Zoology), Liangru Lin(Peking University), Junbin Wang(Kunming Institute of Zoology), Cong Tang(Kunming Institute of Zoology), Yong Shen(Peking University), Xiaojing Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yunlong Cao(Peking University), Zeguang Wu(Peking University), Yiyuan Xu(Peking University)
Cited by 623
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k